Back to Results
First PageMeta Content
Medicine / Antipyretics / Propionic acids / Analgesics / Naproxen / Amides / Aspirin / Indometacin / Rheumatoid arthritis / Non-steroidal anti-inflammatory drugs / Chemistry / Organic chemistry


EC-NAPROSYN (naproxen delayed-release tablets) NAPROSYN (naproxen tablets) ANAPROX/ANAPROX DS (naproxen sodium tablets) NAPROSYN (naproxen suspension) Rx only Cardiovascular Risk
Add to Reading List

Document Date: 2014-03-31 07:24:11


Open Document

File Size: 160,02 KB

Share Result on Facebook

City

Reference / /

Facility

The terminal / /

IndustryTerm

chemical form / chemical names / food intake / food / /

MedicalCondition

Congestive Heart Failure / peptic ulcer / Hypertension / disease / ankylosing spondylitis / arthritis / tendonitis / rheumatoid arthritis / bursitis / nausea / stroke / cardiovascular disease / osteoarthritis / gout / Renal Insufficiency / myocardial infarction / heart failure / urticaria / juvenile rheumatoid arthritis / pain in the setting of coronary artery / hypersensitivity / dizziness / peptic ulcers / renal failure / inflammation / joint pain / tinnitus / lightheadedness / inflammatory / Hepatic Insufficiency / asthma / /

MedicalTreatment

alternate therapies / bypass / surgery / /

Organization

Absorption Immediate Release After administration / /

Position

investigator / General / /

Product

talc / ANAPROX DS / EC-NAPROSYN / sodium chloride / DS / NAPROSYN / polyethylene glycol / sorbitol / naproxen / indomethacin / ANAPROX / naproxen sodium / /

Technology

Pharmacokinetics / Pharmacodynamics / /

SocialTag